Single-center prospective study on the efficacy of nivolumab against platinum-sensitive recurrent or metastatic head and neck squamous cell carcinoma
Crossref DOI link: https://doi.org/10.1038/s41598-022-06084-z
Published Online: 2022-02-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Okamoto, Isaku
Tsukahara, Kiyoaki
Sato, Hiroki
Text and Data Mining valid from 2022-02-07
Version of Record valid from 2022-02-07
Article History
Received: 17 September 2021
Accepted: 21 January 2022
First Online: 7 February 2022
Competing interests
: The authors declare no competing interests.